NEW YORK (GenomeWeb News) – Genedata today said that Japanese drug firm Chugai Pharmaceutical is extending its licensing agreement for use of the Genedata Expressionist software.
Chugai uses the product to streamline R&D processes and for enterprise-wide analysis and management of microarray data. Moving ahead, the company plans to use the software to analyze data for personalized medicine. In a statement, Junichi Muroya, of Chugai's bioinformatics department, said that in addition to day-to-day analysis, the company will explore using the software for next-generation sequencing.
Financial and other terms of the extension were not disclosed.
Chugai has used Genedata's software since at least 2007 to analyze high-throughput screening data.